Skip to the page

Data / Drug companies / Hydrocodone bitartrate and acetaminophen

Hydrocodone bitartrate and acetaminophen: 37 companies and 202 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Hydrocodone bitartrate and acetaminophen is listed in the FDA National Drug Code Directory by 37 companies, with 202 products in commercial distribution. 202 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution; liquid, and the newest product started marketing on October 29, 2025.

The request: Get every company that lists hydrocodone bitartrate and acetaminophen in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
37
Products
202
Generic (ANDA) products
202 (100.0%)
Application numbers
27
Controlled substance schedule
Schedule II
Routes
Oral
openFDA record search
api.fda.gov

Companies that list hydrocodone bitartrate and acetaminophen

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bryant Ranch Prepack30tabletGeneric drugs (ANDA)November 8, 2018
Bryant Ranch Prepack29tabletGeneric drugs (ANDA)September 1, 2020
Bryant Ranch Prepack15tabletGeneric drugs (ANDA)June 17, 2019
Cranbury Pharmaceuticals, LLC8tablet; solutionGeneric drugs (ANDA)December 30, 2021
XLCare Pharmaceuticals, Inc.8tabletGeneric drugs (ANDA)February 27, 2020
Eywa Pharma Inc7tablet; solutionGeneric drugs (ANDA)June 17, 2019
NuCare Pharmaceuticals,Inc.7tabletGeneric drugs (ANDA)July 13, 2018
Asclemed USA, Inc.6tabletGeneric drugs (ANDA)April 12, 2016
Aurolife Pharma, LLC6tabletGeneric drugs (ANDA)May 6, 2015
KVK-Tech, Inc.6tabletGeneric drugs (ANDA)June 22, 2017
Lupin Pharmaceuticals,Inc.6tabletGeneric drugs (ANDA)December 1, 2016
SpecGx LLC6tabletGeneric drugs (ANDA)March 31, 2017
Proficient Rx LP5tabletGeneric drugs (ANDA)April 12, 2012
St. Mary's Medical Park Pharmacy5tabletGeneric drugs (ANDA)October 29, 2025
American Health Packaging4tablet; solutionGeneric drugs (ANDA)June 27, 2023
Camber Pharmaceuticals, Inc.4tabletGeneric drugs (ANDA)August 22, 2025
Elite Laboratories, Inc.4tabletGeneric drugs (ANDA)November 16, 2018
Redpharm Drug4solution; tabletGeneric drugs (ANDA)October 15, 2023
Asclemed USA Inc.3tabletGeneric drugs (ANDA)July 13, 2018
AvPAK3tabletGeneric drugs (ANDA)October 28, 2016
Direct_Rx3tabletGeneric drugs (ANDA)April 26, 2022
Epic Pharma, LLC3tabletGeneric drugs (ANDA)April 2, 2018
Granules Pharmaceuticals Inc.3tabletGeneric drugs (ANDA)August 18, 2021
Pai Holdings, LLC DBA Pai Pharma3solutionGeneric drugs (ANDA)July 29, 2013
Proficient Rx LP3tabletGeneric drugs (ANDA)September 1, 2025
Rhodes Pharmaceuticals LLC3tabletGeneric drugs (ANDA)April 12, 2016
Strides Pharma Science Limited3tabletGeneric drugs (ANDA)September 1, 2025
Upsher-Smith Laboratories, LLC3tabletGeneric drugs (ANDA)March 27, 2017
Amneal Pharmaceuticals of New York LLC2tabletGeneric drugs (ANDA)February 18, 2010
Genus Lifesciences2solutionGeneric drugs (ANDA)October 15, 2023
Quality Care Products, LLC2tabletGeneric drugs (ANDA)April 6, 2023
A-S Medication Solutions1tabletGeneric drugs (ANDA)October 20, 2000
Amneal Pharmaceuticals LLC1tabletGeneric drugs (ANDA)June 30, 2016
Golden State Medical Supply, Inc.1tabletGeneric drugs (ANDA)October 20, 2000
Hikma Pharmaceuticals USA Inc.1liquidGeneric drugs (ANDA)June 2, 2025
NuCare Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)April 11, 2012
Proficient Rx LP1tabletGeneric drugs (ANDA)November 8, 2018

Dosage forms

Dosage formProductsShare
Tablet19094.1%
Solution115.4%
Liquid10.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)202100%

Pharmacologic classes

ClassProducts
Opioid Agonist202

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.